265 related articles for article (PubMed ID: 30012308)
21. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
Arnall JR; Petro R; Patel JN; Kennedy L
J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
[TBL] [Abstract][Full Text] [Related]
22. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
[TBL] [Abstract][Full Text] [Related]
23. The current status and problems confronted in delivering precision medicine in Japan and Europe.
Bando H
Curr Probl Cancer; 2017; 41(3):166-175. PubMed ID: 28391973
[TBL] [Abstract][Full Text] [Related]
24. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
Morgan G; Aftimos P; Awada A
Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
[TBL] [Abstract][Full Text] [Related]
25. Precision medicine: opportunities, possibilities, and challenges for patients and providers.
Adams SA; Petersen C
J Am Med Inform Assoc; 2016 Jul; 23(4):787-90. PubMed ID: 26977101
[TBL] [Abstract][Full Text] [Related]
26. Conceptual endophenotypes: A strategy to advance the impact of psychoneuroendocrinology in precision medicine.
Hellhammer D; Meinlschmidt G; Pruessner JC
Psychoneuroendocrinology; 2018 Mar; 89():147-160. PubMed ID: 29396321
[TBL] [Abstract][Full Text] [Related]
27. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
28. Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities.
Beckmann JS; Lew D
Genome Med; 2016 Dec; 8(1):134. PubMed ID: 27993174
[TBL] [Abstract][Full Text] [Related]
29. Tensions in ethics and policy created by National Precision Medicine Programs.
Minari J; Brothers KB; Morrison M
Hum Genomics; 2018 Apr; 12(1):22. PubMed ID: 29665847
[TBL] [Abstract][Full Text] [Related]
30. Role of Imaging in the Era of Precision Medicine.
Giardino A; Gupta S; Olson E; Sepulveda K; Lenchik L; Ivanidze J; Rakow-Penner R; Patel MJ; Subramaniam RM; Ganeshan D
Acad Radiol; 2017 May; 24(5):639-649. PubMed ID: 28131497
[TBL] [Abstract][Full Text] [Related]
31. The First National Pain Medicine Summit--final summary report.
Lippe PM; Brock C; David J; Crossno R; Gitlow S
Pain Med; 2010 Oct; 11(10):1447-68. PubMed ID: 21199301
[TBL] [Abstract][Full Text] [Related]
32. Brazilian health-care policy for targeted oncology therapies and companion diagnostic testing.
Ferreira CG; Achatz MI; Ashton-Prolla P; Begnami MD; Marchini FK; Stefani SD
Lancet Oncol; 2016 Aug; 17(8):e363-e370. PubMed ID: 27511160
[TBL] [Abstract][Full Text] [Related]
33. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
[TBL] [Abstract][Full Text] [Related]
34. [Breast cancer research in the era of precision medicine].
Yang HY; Jiang YZ; Shao ZM
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):401-3. PubMed ID: 27346395
[TBL] [Abstract][Full Text] [Related]
35. An emerging role for cytopathology in precision oncology.
Pauli C; Puca L; Mosquera JM; Robinson BD; Beltran H; Rubin MA; Rao RA
Cancer Cytopathol; 2016 Mar; 124(3):167-73. PubMed ID: 26641771
[TBL] [Abstract][Full Text] [Related]
36. Implementation of precision medicine in healthcare-A European perspective.
Stenzinger A; Moltzen EK; Winkler E; Molnar-Gabor F; Malek N; Costescu A; Jensen BN; Nowak F; Pinto C; Ottersen OP; Schirmacher P; Nordborg J; Seufferlein T; Fröhling S; Edsjö A; Garcia-Foncillas J; Normanno N; Lundgren B; Friedman M; Bolanos N; Tatton-Brown K; Hill S; Rosenquist R
J Intern Med; 2023 Oct; 294(4):437-454. PubMed ID: 37455247
[TBL] [Abstract][Full Text] [Related]
37. Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
García-Alfonso P; García-Foncillas J; Salazar R; Pérez-Segura P; García-Carbonero R; Musulén-Palet E; Cuatrecasas M; Landolfi S; Ramón Y Cajal S; Navarro S; ;
Clin Transl Oncol; 2015 Apr; 17(4):264-73. PubMed ID: 25373533
[TBL] [Abstract][Full Text] [Related]
38. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
[TBL] [Abstract][Full Text] [Related]
39. Precision Medicine and PET/Computed Tomography: Challenges and Implementation.
Subramaniam RM
PET Clin; 2017 Jan; 12(1):1-5. PubMed ID: 27863561
[TBL] [Abstract][Full Text] [Related]
40. Toward precision medicine and health: Opportunities and challenges in allergic diseases.
Galli SJ
J Allergy Clin Immunol; 2016 May; 137(5):1289-300. PubMed ID: 27155026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
